数字农科院2.0

EGCG-enabled Deep Tumor Penetration of Phosphatase and Acidity Dual-responsive Nanotherapeutics for Combinatory Therapy of Breast Cancer

文献类型： 外文期刊

作者： Zhou, Mengxue;Zhou, Chuang;Geng, Huan;Huang, Zhiwei;Lin, Zhiyuan;Wang, Ying;Zhu, Yin;Shi, Jiang;Tan, Junfeng;Guo, Li;Zhao, Yanni;Zhang, Yue;Peng, Qunhua;Yu, Haijun;Dai, Weidong;Lv, Haipeng;Lin, Zhi

作者机构：

关键词： chemo/chemodynamic therapy;EGCG;nanomedicine;TGF-beta signaling;triple-negative breast cancer

期刊名称： SMALL

ISSN： 1613-6810

年卷期： 2024 年

页码：

收录情况： SCIE（2024版） ; ; EI（2024版）

摘要： The presence of dense collagen fibers is a typical characteristic of triple-negative breast cancer (TNBC). Although these fibers hinder drug penetration and reduce treatment efficacy, the depletion of the collagen matrix is associated with tumor metastasis. To address this issue, epigallocatechin-3-gallate (EGCG) is first exploited for disrupting the dense collagenous stroma and alleviate fibrosis by specifically blocking the TGF-beta/Smad pathway in fibroblasts and tumor cells when intraperitoneally administrated in TNBC tumor-bearing mice. A methotrexate (MTX)-loaded dual phosphate- and pH-responsive nanodrug (pHA@MOF-Au/MTX) is next engineered by integrating Fe-based metal-organic frameworks and gold nanoparticles for improved chemo/chemodynamic therapy of TNBC. Surface modification with pH (low)-insertion peptide substantially enhanced the binding of the nanodrug to 4T1 cells owing to tumor stroma remodeling by EGCG. High-concentration EGCG inhibited glutathione peroxidase by regulating mitochondrial glutamine metabolism, thus facilitating tumor cell ferroptosis. Furthermore, sequential EGCG and pHA@MOF-Au/MTX treatment showed remarkable anti-tumor effects in a mouse model of TNBC, with a tumor growth inhibition rate of 79.9%, and a pulmonary metastasis rate of 96.8%. Altogether, the combination strategy developed in this study can improve the efficacy of chemo/chemodynamic therapy in TNBC and represents an innovative application of EGCG.

分类号：

  • 相关文献

[1]Engineering cannabidiol synergistic carbon monoxide nanocomplexes to enhance cancer therapy via excessive autophagy. Xiao, Chang,Sun, Yue,Fan, Jialong,Nguyen, William,Chen, Simin,Long, Ying,Chen, Wei,Zhu, Aiguo,Liu, Bin. 2023

[2]Native Nanodiscs From Blood Inhibit P.ulmonary Fibrosis. Sun, AQ, Lai, ZY, Zhao, MY, Mu, L, Hu, XG. 2019

[3]Pharmacokinetics modulation in solid tumors through thrombin-embedded nanomedicine. Lin, Sheng,Zhang, Liuwei,Cui, Hongyan,Wang, Yue,Zheng, Yang,Hu, Jianhua,Li, Mingzhu,Wang, Wentao,Zhang, Shijia,Zhou, Kehui,Chen, Qixian,Lan, Xiabin,Zhao, Yan. 2025

[4]Augmenting stealth attributes and intracellular trafficking of polyplex micelles via charge-switching corona for superior gene transduction. Changgui Tong,Yan Zhao,Sheng Lin,Yong Zhang,Qixian Chen,Yue Wang. 2025

[5]A One-Two Punch Strategy Against Cancer: Simultaneously Inducing and Eliminating Senescent Tumor Cells. Fang, Bo,Pan, Fei,Chen, Sailing,Tian, Wenli,Zhu, Yang,Shen, Yaobang,Wang, Hao,Guo, Hui,Ding, Yuan,Wang, Yuhao,Li, Gaopeng,Xu, Daqian,Sun, Zhongquan,Li, Xiao,Mao, Zhengwei. 2025

[6]表没食子儿茶素没食子酸酯参与老年小鼠心脏SERCA2a的调控及其机制. 全珺珺,潘博,贾忠莉,刘玲娟,田杰. 2017

[7]茶与健康研究的前景与挑战. 陈宗懋. 2019

[8]茶叶中EGCG对小鼠抗凝血作用实验研究. 王贤波,成浩,赵芸,黄海涛. 2011

[9]EGCG甲基化衍生物的清除DPPH自由基活性和总抗氧化活性. 吕海鹏,林智,谭俊峰,郭丽,张悦,费旭元. 2011

[10]茶与健康专题(六)茶的杀菌和抗病毒功效. 陈宗懋. 2009

[11]传统SMB、Varicol和Partial-discard工艺分离纯化ECG和EGCG的比较研究. 黄永东,江和源,江用文,张建勇,王斌,白艳,文志浩,王伟伟. 2011

[12]茶与健康专题(八)茶叶抗癌的效果:过去、现在和将来. 陈宗懋. 2009

[13]介孔氧化硅SBA-15作为高效吸附剂用于绿茶提取物中EGCG的选择性吸附研究. 马桂岑,章剑扬,陈利燕,张颖彬,刘新. 2014

[14]乙酰化EGCG的制备研究. 刘晓辉,江和源,张建勇,袁新跃,崔宏春. 2009

[15]SMB、Varicol和Partial-discard工艺分离茶多酚. 黄永东,江和源,江用文,王斌. 2010

[16]EGCG乙酰化衍生物清除自由基活性的构效分析. 王伟伟,苏威,江和源,张建勇,施莉婷. 2017

[17]EGCG纳米载体制备技术及其对EGCG活性影响的研究进展. 祁洁,徐颖磊,梁文怡,费朵,乌昕儿,金建昌,杜琪珍,许勇泉,高颖. 2017

[18]PBD和RSM联用优化聚酯型儿茶素A化学合成技术参数. 张建勇,陈琳,崔宏春,王伟伟,薛金金,熊春华,江和源. 2020

[19]茶叶中EGCG的制备化分离新技术. 杜琪珍,沈星荣,蒋迎. 2000

[20]儿茶素生物医用纳米材料研究进展. 俞蓉欣,郑芹芹,陈红平,张劲松,张相春. 2022

作者其他论文 更多>>